Evidence map›Paper›PMID 39359164›Full record

Trial reportAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2024

Effect of Intensive Blood Pressure Lowering on the Risk of Incident Silent Myocardial Infarction: A Post Hoc Analysis of a Randomized Controlled Trial.

Richard Kazibwe, Muhammad Imtiaz Ahmad, Sanjay Singh, Lin Y Chen, Elsayed Z Soliman

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01206062 (Systolic Blood Pressure Intervention Trial), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01206062 nacompletednot on this map

Systolic Blood Pressure Intervention Trial

TypeinterventionalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2010 to 2019Enrolled9,361ConditionsHypertensionArmsIntensive control of SBP, Standard control of SBP
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Richard KazibweDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0001-7085-3373
Muhammad Imtiaz AhmadDepartment of Internal Medicine, Section on Hospital Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.ORCID 0000-0002-6870-1722
Sanjay SinghDepartment of Internal Medicine, Section on Hospital Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Lin Y ChenLillehei Heart Institute and Cardiovascular Division, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Elsayed Z SolimanEpidemiological Cardiology Research Center (EPICARE), Department of Internal Medicine, Cardiovascular Section, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Funding

1995 SUMMER INSTITUTE IN GERIATRIC MEDICINER13AG013039 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WILKING, SPENCER VAN B. · 1995 to 1995
–
Interagency Agreement Number A-HL-13-002-001National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)National Institute on Aging (NIA) 10.13039/100000049National Institutes of Health (NIH) 10.13039/100000002the National Institute of Neurological Disorders and Stroke (NINDS), under Contract Numbers HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C
6 · The paper itself

Abstract

backgroundSilent myocardial infarction (SMI) frequently goes undetected, yet it is associated with increased cardiovascular morbidity and mortality. The impact of intensive systolic blood pressure (SBP) lowering on the risk of SMI in those with hypertension remains uncertain.

methodsIn this post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), participants with serial electrocardiograms (ECGs) during the trial were included. SPRINT investigated the benefit of intensive SBP lowering, aiming for < 120 mmHg compared to the standard SBP goal of < 140 mmHg. Incident SMI was defined as evidence of new MI on an ECG without adjudicated recognized myocardial infarction (RMI).

resultsDuring a median follow-up of 3.9 years, a total of 234 MI events (55 SMI and 179 RMI) occurred. Intensive, compared to standard, SBP lowering resulted in a lower rate of SMI (incidence rate 1.1 vs. 2.3 cases per 1000 person-years, respectively; HR [95% CI]: 0.48 [0.27-0.84]). Similarly, intensive, compared to standard, BP lowering reduced the risk of RMI (incidence rate 4.6 vs. 6.5 cases per 1000 person-years, respectively; HR [95% CI]: 0.71 [0.52-0.95]). No significant differences were noted between the strength of the association of intensive BP control on lowering the risk of SMI and RMI (p-value for HR differences = 0.23).

conclusionsThis study shows that in adults with hypertension, the benefits of intensive SBP lowering, compared with standard BP lowering, go beyond the prevention of RMI to include the prevention of SMI.

trial registrationClinicalTrials.gov Identifier: NCT01206062.

Indexed as

Antihypertensive AgentsElectrocardiographyHypertensionMyocardial InfarctionAgedBlood PressureFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedRisk FactorsAntihypertensive Agentsblood pressure controlsilent myocardial infarctionSPRINT

Identifiers

PMID39359164
PMCPMC11447273

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.